Louis Falo Jr., MD, PhD

University of Pittsburgh

Dr. Louis D. Falo, Jr. is Professor and Chair of the Department of Dermatology at the University of Pittsburgh School of Medicine. Dr. Falo is a graduate of Harvard Medical School, where he earned both his MD and PhD degrees with a research interest in skin immunology. He completed an internship in internal medicine at Massachusetts General Hospital, a dermatology residency through the Harvard Dermatology Program and a fellowship in cancer research at the Dana Farber Cancer Institute. Before coming to the University of Pittsburgh and University of Pittsburgh Medical Center, he was a member of the Harvard faculty in the Department of Dermatology and at the Dana Farber Cancer Institute.  In addition to Dermatology, Dr. Falo has faculty appointments in the School of Engineering, Dept of Bioengineering, the Pittsburgh Clinical and Translational Science Institute, the University of Pittsburgh Cancer Institute, and the McGowan Institute for Regenerative Medicine.  Dr. Falo leads a very active research program that has been continuously funded by the NIH for over 20 years. His current research efforts focus on the development of platform technologies for skin-targeted vaccines, immunotherapies, and immunomodulatory strategies. Clinically, Dr. Falo is the Director of the Occupational and Contact Dermatitis Program, and maintains an avid interest in the translational development of therapies for autoimmune diseases and non-melanoma skin cancers and is currently participating in clinical trials of novel immune therapies for skin cancers. Dr. Falo is an elected
member of the American Society for Clinical Investigation, the Association of American Physicians, and is a two-time winner of the University’s Innovator Award, inventor of several patented discoveries, and Co-Founder of SkinJect, Inc, a company focusing on the development of novel therapies for skin cancer.